Symbicort asthma action plan (Rapihaler)

Symbicort anti-inflammatory reliever +/- maintenance action plans

Symbicort asthma action plan (Rapihaler)

This asthma action plan is specifically for patients using the combination medication Symbicort (budesonide and formoterol) as an anti-inflammatory reliever with or without maintenance.

Note: Symbicort is not recommended for use in Australia in children under 12 years.

Order print copies

The Symbicort asthma action plans were independently developed by clinicians. Hard copies can be ordered from AstraZeneca via local representatives or by calling 1800 805 342.

Note

These are symptom based asthma action plans. Copies of the peak flow based action plan are available from AstraZeneca.